Donate
Follow-up Guidelines
Community Physician Information
As part of our responsibility to establish a coordinated, province-wide program of cancer control for residents of Saskatchewan, and to support physicians working in the community setting, the Saskatchewan Cancer Agency has prepared cancer follow-up guidelines (listed below), based on our accumulated experiences. The recommendations have been developed by tumour groups comprised of oncologists and hematologists at the Cancer Agency.
The following guidelines are a statement of consensus of its authors regarding their views of currently accepted approaches to treatment. Any clinician seeking to apply or consult the guidelines is expected to use independent medical judgment in the context of individual clinical circumstances to determine any patient's care or treatment.
Breast
- Follow-up Guidelines
- Criteria for Discharge
- Discharge Letters:
- For Patients on Aromatase Inhibitor (Anastrozole, Letrozole and Exemestane)
- For Patients on Tamoxifen
- For Patients Not on any Treatment
- Discharge Letters:
Central Nervous System
B-Cell Chronic Lymphocytic Leukemia (CLL)
Gastro-Intestinal
- Biliary Tract and Gall Bladder - Follow-up Guidelines
- Biliary Tract and Gall Bladder - Discharge Letter
- Colorectal - Follow-up Guidelines
- Colorectal Stage 1 - Discharge Letter
- Colorectal Stage 2/3 - Discharge Letter
- Gastro-Esophagael Junction - Follow-up Guidelines
- Gastro-Esophagael Junction & Gastric Cancer - Surgery After Chemo or Chemo-Radiotherapy - Discharge Letter
- Gastro-Esophagael Junction & Gastric Cancer - Endoscopic Resection - Discharge Letter
- Esophagael Cancer - Discharge Letter
- GI Discharge Pathway
- Hepatocellular - Follow-up Guidelines
- Pancreatic - Follow-up Guidelines
- Pancreatic - Discharge Letter
Genito-Urinary
- Neoadjuvant Bladder Cancer - Discharge Letter
- Non-Metastatic Bladder Cancer - Discharge Letter
- Genitourinary Discharge Care Pathway
- Post Prostate Radiotherapy - Follow-up Guidelines
- Localized Prostate Cancer - Discharge Letter
- Localized Renal Cancer Following Surgery - Discharge Letter
- Seminoma Stage 1, Post Treatment - Discharge Letter
- Seminoma Stage IIA and Non-Bulky IIB, Post Treatment - Discharge Letter
- Seminoma Stage IIB Bulky, IIC and III, Post Treatment - Discharge Letter
Gyne-Oncology
- Cervical - Follow-up Guidelines
- Endometrial - Follow-up Guidelines
- Gestational Trophoplastic Neoplasia - Follow-up Guidelines
- Ovarian - Follow-up Guidelines
- Vulvar - Follow-up Guidelines
Head and Neck
Hodgkin's Lymphoma
Lung Cancer
- Small Cell Lung - Follow-up Guidelines
- Small Cell Lung - Discharge Letter
- Non-Small Cell Lung - Follow-up Guidelines
- Non-Small Cell Lung Cancer - Discharge Letter
- Pathway of Care after Treatment
Melanoma
Neuroendocrine
Non-Hodgkin's Lymphoma
- NHL High Grade Follow-up Guidelines
- NHL High Grade Discharge Care Pathway
- NHL High Grade Discharge Letter
- NHL Low Grade Follow-up Guidelines
- NHL Low Grade Discharge Letter
Thyroid